EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Lowering P CO 2 With Noninvasive Ventilation Is Associated With Improved Survival in Chronic Hypercapnic Respiratory Failure

Jose Victor Jimenez, Jason Ackrivo, Jesse Y Hsu, Mathew W Wilson, Wassim W Labaki, John Hansen-Flaschen, Robert C Hyzy, Philip J Choi

Respiratory Care · 2023-12 · 68 (12) · 1613-1622

DOI: 10.4187/respcare.10813 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND: Chronic hypercapnic respiratory failure is associated with high mortality. Although previous work has demonstrated a mortality improvement with high-intensity noninvasive ventilation in COPD, it is unclear whether a P CO 2 reduction strategy is associated with improved outcomes in other populations of chronic hypercapnia. METHODS: The objective of this study was to investigate the association between P CO 2 reduction (by using transcutaneous P CO 2 as an estimate for P aCO 2 and survival in a broad population of individuals treated with noninvasive ventilation for chronic hypercapnia. We hypothesized that reductions in P CO 2 would be associated with improved survival. Therefore, we performed a cohort study of all the subjects evaluated from February 2012 to January 2021 for noninvasive ventilation initiation and/or optimization due to chronic hypercapnia at a home ventilation clinic in an academic center. We used multivariable Cox proportional hazard models with time-varying coefficients and P CO 2 as a time-varying covariate to test the association between P CO 2 and all-cause mortality and when adjusting for known cofounders. RESULTS: The mean ± SD age of 337 subjects was 57 ± 16 years, 37% women, and 85% white. In a univariate analysis, survival probability increased with reductions in P CO 2 to < 50 mm Hg after 90 d, and these remained significant after adjusting for age, sex, race, body mass index, diagnosis, Charlson comorbidity index, and baseline P CO 2 . In the multivariable analysis, the subjects who had a P aCO 2 < 50 mm Hg had a reduced mortality risk of 94% between 90 and 179 d (hazard ratio [HR] 0.06, 95% CI 0.01–0.50), 69% between 180 and 364 d (HR 0.31, 95% CI 0.12–0.79), and 73% for 365–730 d (HR 0.27, 95% CI 0.13–0.56). CONCLUSIONS: Reduction in P CO 2 from baseline for subjects with chronic hypercapnia treated with noninvasive ventilation was associated with improved survival. Management strategies should target the greatest attainable reductions in P CO 2 .

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →